• Zepbound vs Wegovy trial and compounded GLP-1s

  • Dec 9 2024
  • Length: 44 mins
  • Podcast

Zepbound vs Wegovy trial and compounded GLP-1s

Listen for free

View show details

  • Summary

  • Drs. Karl and Spencer discuss the topline results from Surmount 5 which put Zepbound (tirzepatide) against Wegovy (semaglutide) for weight loss. They also discuss some news around compounded GLP-1s.

    Learn:

    Weight loss and glycemic differences between tirzepatide and semaglutide

    What the FDA is thinking for compounded GLP-1s

    If you're not on Dr. Spencer's virtual clinic waitlist, click here
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Zepbound vs Wegovy trial and compounded GLP-1s

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available